Immunome, Inc. (IMNM)

21.50 -0.64 (-2.89%) USD  |  NASDAQ  |  Feb 20, 16:00
21.51 +0.01 (+0.05%) After-Hours: 20:00
More

Immunome Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for IMNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
Prelude Therapeutics, Inc. Upgrade
Eli Lilly & Co. Upgrade
Relay Therapeutics, Inc. Upgrade
Context Therapeutics, Inc. Upgrade
Moderna, Inc. Upgrade